Items where authors include "Sakurikar, N."

Article

Sakurikar, N., Thompson, R., Montano, R. et al. (1 more author) (2015) A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase. Oncotarget, 7. pp. 1380-1394.